Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2024-04-21 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2023年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2023 年年度报告全文" which translates to "2023 Annual Report Full Text" for 盈康生命科技股份有限公司 (INKON Life Technology Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management commentary, and comprehensive disclosures required for an annual report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-21 Chinese
国泰君安证券股份有限公司关于盈康生命科技股份有限公司2023年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from Guotai Junan Securities Co., Ltd. regarding the 2023 annual special verification opinion on the deposit and use of raised funds by Yingkang Life Technology Co., Ltd. It includes specific financial figures about the raised funds, their usage, management, and compliance with regulatory requirements. The document references regulatory guidelines and includes an auditor's verification opinion. The content focuses on the management and use of capital raised through a non-public stock issuance, with no indication that this is an announcement or a brief summary. The document length is 4638 characters, which is borderline but contains substantive financial data and detailed analysis of the use of raised funds. This fits the definition of an Audit Report / Information (AR), as it is a standalone audit and verification report on the use of raised funds, not a full annual report or a simple announcement. Therefore, the correct classification is AR with high confidence. FY 2023
2024-04-21 Chinese
国泰君安证券股份有限公司关于盈康生命科技股份有限公司重大资产购买暨关联交易之2023年度业绩承诺实现情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a specialized verification opinion from an independent financial advisor (Guotai Junan Securities) regarding the fulfillment of performance commitments related to a major asset purchase and related party transaction by Yingkang Life Technology Co., Ltd. It discusses the 2023 performance commitment achievement, referencing audited financial results and compensation mechanisms. The document is not a full annual report or audit report but a specific verification opinion related to a transaction and performance commitments. It is a standalone audit-related opinion on a specific matter, not a general audit report or annual report. Therefore, it fits best under Audit Report / Information (AR). The document length is 2047 characters, which is short but contains substantive audit verification content, not just an announcement or certification letter, so it is not RPA or RNS. FY 2023
2024-04-21 Chinese
独立董事2023年度述职报告（唐功远）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director of a company for the year 2023. It includes descriptions of the director's attendance at board and shareholder meetings, opinions on various company matters including financial reports, internal controls, audit firm appointments, related party transactions, stock incentive plans, and governance activities. The document is not a financial report itself but a governance-related report focusing on the director's duties and oversight activities. It does not contain financial statements or earnings data, nor is it a brief announcement or a transcript. The content aligns with a Board/Management Information report, specifically about the independent director's annual duties and opinions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (9107 characters) supports it being a full report rather than a brief announcement.
2024-04-21 Chinese
2023年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "审计报告" (Audit Report) for 盈康生命科技股份有限公司, including detailed audit opinions, basis of audit, key audit matters, and extensive financial statement notes for the fiscal year ending December 31, 2023. It contains the auditor's opinion, audit scope, management responsibilities, and detailed accounting policies and estimates. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the definition of an Audit Report / Information (AR) as it is a standalone audit report with detailed financial statements and notes, not a full Annual Report (10-K) which would include broader business and management discussion. Therefore, the correct classification is AR with high confidence. FY 2023
2024-04-21 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the sixth meeting of the sixth Supervisory Board of Yingkang Life Technology Co., Ltd. It includes approvals of various reports related to the 2023 fiscal year, such as the Supervisory Board Work Report, General Manager Work Report, the full 2023 Annual Report and its summary, the 2023 Financial Final Accounts Report, the 2023 Internal Control Self-Evaluation Report, and other related financial and operational matters. The document references the 2023 Annual Report multiple times and states that the Supervisory Board has reviewed and approved the full 2023 Annual Report and its summary, confirming the accuracy and completeness of the report. The document is not the Annual Report itself but a formal announcement of the Supervisory Board's resolutions regarding the Annual Report and other related reports, including the submission of these reports to the 2023 Annual General Meeting for approval. The document length is 5874 characters, which is relatively short and mainly serves as a meeting resolution announcement rather than containing the full financial statements or detailed report content. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of meeting resolutions and approvals related to the Annual Report and other reports, not the reports themselves.
2024-04-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.